(SCL) SCLERODERMA 70 ANTIBODIES, TOPOISOMERASE 1

NABL
Accredited Lab
FREE Sample
Collection
FREE Report Counselling
& Diet Consultation
Fast & Accurate
Test Reports
What is this Test About?
Antibodies to Scl-70 (DNA topoisomerase I) are detected in nearly 75% patients with Progressive Systemic Sclerosis (PSS). Patients of Scleroderma with Scl-70 antibody positivity are associated with diffuse cutaneous involvement, increased frequency of pulmonary fibrosis and high mortality Centromere antibodies are most often associated with lower frequency of pulmonary fibrosis and mortality although an increased risk for pulmonary hypertension has been observed.
Get a call back from our Health Advisor